• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病患者的心血管疾病

Cardiovascular disease in diabetic patients.

作者信息

Goldberg R B

机构信息

Department of Medicine, University of Miami, Florida, USA.

出版信息

Med Clin North Am. 2000 Jan;84(1):81-93, viii. doi: 10.1016/s0025-7125(05)70208-x.

DOI:10.1016/s0025-7125(05)70208-x
PMID:10685129
Abstract

Cardiovascular disease is the most frequent cause of morbidity and mortality in patients with diabetes. This article evaluates the results of clinical interventions that have been tested for their ability to ameliorate cardiovascular disease through identification and management of cardiovascular risk factors. These include hyperglycemia, insulin resistance, dyslipidemia, hypertension, cigarette smoking, and a procoagulant state. Attention to all cardiovascular risk factors is necessary if physicians are to reduce the burden of these complications in diabetic patients.

摘要

心血管疾病是糖尿病患者发病和死亡的最常见原因。本文评估了一些临床干预措施的效果,这些措施已通过识别和管理心血管危险因素来测试其改善心血管疾病的能力。这些危险因素包括高血糖、胰岛素抵抗、血脂异常、高血压、吸烟和促凝状态。如果医生想要减轻糖尿病患者这些并发症的负担,关注所有心血管危险因素是必要的。

相似文献

1
Cardiovascular disease in diabetic patients.糖尿病患者的心血管疾病
Med Clin North Am. 2000 Jan;84(1):81-93, viii. doi: 10.1016/s0025-7125(05)70208-x.
2
Mortality after myocardial infarction in patients with diabetes mellitus.糖尿病患者心肌梗死后的死亡率
Heart. 2007 Dec;93(12):1504-6. doi: 10.1136/hrt.2006.112656.
3
Rethinking treatment for patients with diabetes and cardiovascular disease.重新思考糖尿病和心血管疾病患者的治疗方法。
JAMA. 2002 May 15;287(19):2488-91.
4
The Munich Myocardial Infarction Registry: translating the European Society of Cardiology (ESC) and European Association for the Study of Diabetes (EASD) guidelines on diabetes, pre-diabetes, and cardiovascular disease into clinical practice.慕尼黑心肌梗死注册研究:将欧洲心脏病学会(ESC)和欧洲糖尿病研究协会(EASD)关于糖尿病、糖尿病前期和心血管疾病的指南转化为临床实践。
Diabetes Care. 2009 Nov;32 Suppl 2(Suppl 2):S326-30. doi: 10.2337/dc09-S332.
5
Prevention and management of cardiovascular disease in patients with diabetes mellitus: an evidence base.糖尿病患者心血管疾病的预防与管理:循证依据
Diabet Med. 1996 Sep;13(9 Suppl 4):S101-21.
6
Diabetes mellitus and myocardial infarction: a time to act or a time to wait?
Diabet Med. 1998 Apr;15(4):275. doi: 10.1002/(SICI)1096-9136(199804)15:4<275::AID-DIA589>3.0.CO;2-I.
7
Risk factors for cardiovascular mortality and morbidity: the WHO Mutinational Study of Vascular Disease in Diabetes.心血管疾病死亡率和发病率的风险因素:世界卫生组织糖尿病血管疾病多国研究
Diabetologia. 2001 Sep;44 Suppl 2:S54-64. doi: 10.1007/pl00002940.
8
[Type 2 diabetes mellitus and cardiovascular diseases: evaluation, treatment and prevention strategies].[2型糖尿病与心血管疾病:评估、治疗及预防策略]
Harefuah. 2006 Feb;145(2):141-6, 164.
9
Interplay of diabetes and coronary heart disease on cardiovascular mortality.糖尿病与冠心病对心血管死亡率的相互作用。
Heart. 2004 Dec;90(12):1371-3. doi: 10.1136/hrt.2004.035766.
10
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.欧洲心脏病学会(ESC)与欧洲糖尿病研究协会(EASD)合作制定的糖尿病、糖尿病前期和心血管疾病指南——总结
Diab Vasc Dis Res. 2014 May;11(3):133-73. doi: 10.1177/1479164114525548.

引用本文的文献

1
Ten-Year Cardiovascular Risk as Predicted by the QRISK®3 Calculator in Diabetic Patients Attending a Tertiary Care Teaching Hospital in Central India and Its Application to Stratify Statin Over-Users and Under-Users.印度中部一家三级护理教学医院的糖尿病患者中,通过QRISK®3计算器预测的十年心血管风险及其在他汀类药物使用过量和使用不足分层中的应用。
Cureus. 2023 Oct 17;15(10):e47213. doi: 10.7759/cureus.47213. eCollection 2023 Oct.
2
Association of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use With Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus Patients With Stabilized Acute Myocardial Infarction: A Propensity Score Matching Study.钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂的使用与急性心肌梗死病情稳定的2型糖尿病患者心血管和肾脏结局的关联:一项倾向评分匹配研究
Front Cardiovasc Med. 2022 Apr 29;9:882181. doi: 10.3389/fcvm.2022.882181. eCollection 2022.
3
Diabetes mellitus and its impact on mortality rate and outcome in pulmonary embolism.糖尿病及其对肺栓塞死亡率和预后的影响。
J Diabetes Investig. 2022 Apr;13(4):725-737. doi: 10.1111/jdi.13710. Epub 2021 Dec 1.
4
The Management and Prognostic Factors of Acute Coronary Syndrome: Evidence from the Taiwan Acute Coronary Syndrome Full Spectrum Registry.急性冠状动脉综合征的管理与预后因素:来自台湾急性冠状动脉综合征全谱注册研究的证据
Acta Cardiol Sin. 2017 Jul;33(4):329-338. doi: 10.6515/acs20161205a.
5
Diabetes and Adverse Cardiovascular Outcomes in Patients with Acute Coronary Syndrome - Data from Taiwan's Acute Coronary Syndrome Full Spectrum Data Registry.急性冠状动脉综合征患者的糖尿病与不良心血管结局——来自台湾急性冠状动脉综合征全谱数据登记处的数据
Acta Cardiol Sin. 2016 Jan;32(1):31-8. doi: 10.6515/acs20150322a.
6
Atypical presentation of acute and chronic coronary artery disease in diabetics.糖尿病患者急性和慢性冠状动脉疾病的非典型表现。
World J Cardiol. 2014 Aug 26;6(8):802-13. doi: 10.4330/wjc.v6.i8.802.
7
Prevalence of diabetes and other cardiovascular risk factors in an Iranian population with acute coronary syndrome.伊朗急性冠状动脉综合征患者中糖尿病及其他心血管危险因素的患病率。
Cardiovasc Diabetol. 2006 Jul 17;5:15. doi: 10.1186/1475-2840-5-15.
8
Lipid, lipoproteins, C-reactive protein, and hemostatic factors at baseline in the diabetes prevention program.糖尿病预防计划中基线时的脂质、脂蛋白、C反应蛋白及止血因子。
Diabetes Care. 2005 Oct;28(10):2472-9. doi: 10.2337/diacare.28.10.2472.
9
[Cardiovascular risk and glucose metabolism: agreements and discrepancies between the WHO-85 and ADA-97 classifications].[心血管风险与葡萄糖代谢:世界卫生组织1985年和美国糖尿病协会1997年分类之间的共识与分歧]
Aten Primaria. 2002 Mar 15;29(4):205-12. doi: 10.1016/s0212-6567(02)70544-1.
10
Evidence for a circulating islet cell growth factor in insulin-resistant states.胰岛素抵抗状态下循环胰岛细胞生长因子的证据。
Proc Natl Acad Sci U S A. 2001 Jun 19;98(13):7475-80. doi: 10.1073/pnas.131192998. Epub 2001 Jun 12.